title: [Quality assurance of haemotherapy in anaesthesia. Auswertung eines 3-jahrigen Erfahrungszeitraums].
abstract: BACKGROUND
  The measures for quality assurance in haemotherapy developed at the Charite Campus Mitte according to the transfusion law of 1998 are introduced and discussed.
  
  
  METHODS
  In a 3-year study period the submission of transfusion documentation and the expiration of blood products were compared to the year 2001. The potentials for improvement for 2001-2003 were compared based on evaluation of the self-inspection documentation of the transfusion clinics.
  
  
  RESULTS
  The submission rate for the transfusion documentation increased from 90% in 2001 to 98.3% in 2002 and 2003. The expiration of blood products decreased from 5.1% in 2001 to 1.7% in 2003 resulting in a cost reduction from 140,000 Euro to 50,000 Euro. Continuous need for improvement was found for the prescribed annual further education of staff on quality management.
  
  
  CONCLUSIONS
  The self-inspection procedure in transfusion clinics still revealed potential for improvement, although documentation of transfusions were improved and the expiration of blood products and the resulting costs were substantially reduced.
authors.affiliation: Klinik für Anästhesiologie und operative Intensivmedizin, Charité-Universitätsmedizin Berlin, Campus Charité Mitte. christian.von_heymann@charite.de
authors.forename: C
authors.initials: C
authors.lastname: von Heymann
authors.forename: A
authors.initials: A
authors.lastname: Pruss
authors.forename: A
authors.initials: A
authors.lastname: Foer
authors.forename: T
authors.initials: T
authors.lastname: Volk
authors.forename: J
authors.initials: J
authors.lastname: Braun
authors.forename: A
authors.initials: A
authors.lastname: Röhrs
authors.forename: H
authors.initials: H
authors.lastname: Kiesewetter
authors.forename: C
authors.initials: C
authors.lastname: Spies
mesh_terms: D000758:Anesthesia; D001793:Blood Preservation; D001803:Blood Transfusion / Q000191:economics / Q000331:legislation & jurisprudence; D003362:Cost-Benefit Analysis; D003953:Diagnosis-Related Groups; D004282:Documentation; D004906:Erythrocyte Count; D005858:Germany; D006801:Humans; D011785:Quality Assurance, Health Care / Q000331:legislation & jurisprudence; D065227:Transfusion Reaction